bearish
WuXi Biologics: Pass on This Valuation
732 Views27 May 2017 01:58
The company's underwriters have announced a price range of HK$18.60 - HK$20.60 which implies a market cap of US$2.7-3.0 billion. We recommend...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 3-minute read)
Discussions
(Paid Plans Only)
Kemp Dolliver, CFA
Founder
- "Exchange Arbitrage" For Early-Stage Biotech!21 Jan 2018
- Wuxi Biologics Placement - Selldown Right when Lockup Expires Suggests Eagerness to Offload13 Dec 2017
- WuXi Biologics IPO Review - An Opportunity to Get Exposure to Biologics in China01 Jun 2017
- WuXi Biologics: Pass on This Valuation27 May 2017
- WuXi Biologics: Updated Valuation Data17 May 2017
- An Early Look at WuXi Biologics15 Feb 2017
- Samsung BioLogics IPO Valuation Debate18 Aug 2016
x